APA (7th ed.) Citation

Driedger, J. H., Schröter, J., Group, P., Syrbe, S., & Saffari, A. Long-term neuropsychologic outcome of pre-emptive mTOR inhibitor treatment in children with tuberous sclerosis complex (TSC) under 4 months of age (PROTECT), a two-arm, randomized, observer-blind, controlled phase IIb national multicentre clinical trial: Study protocol. BMC.

Chicago Style (17th ed.) Citation

Driedger, Jan H., Julian Schröter, PROTECT-Study Group, Steffen Syrbe, and Afshin Saffari. Long-term Neuropsychologic Outcome of Pre-emptive MTOR Inhibitor Treatment in Children with Tuberous Sclerosis Complex (TSC) Under 4 months of Age (PROTECT), a Two-arm, Randomized, Observer-blind, Controlled Phase IIb National Multicentre Clinical Trial: Study Protocol. BMC.

MLA (9th ed.) Citation

Driedger, Jan H., et al. Long-term Neuropsychologic Outcome of Pre-emptive MTOR Inhibitor Treatment in Children with Tuberous Sclerosis Complex (TSC) Under 4 months of Age (PROTECT), a Two-arm, Randomized, Observer-blind, Controlled Phase IIb National Multicentre Clinical Trial: Study Protocol. BMC.